Arunaya Organics FY26 net profit falls 12% despite revenue growth
Arunaya Organics reported a 12% decline in FY26 net profit to ₹371.85 lakh, despite a 25% increase in revenue to ₹10,324.78 lakh, driven by higher tax expenses. The statutory auditor issued a qualified opinion regarding outstanding foreign exchange payments and receivables exceeding six months, though financial figures remain unchanged. The company utilized ₹2,150.80 lakh of its IPO proceeds, with ₹900 lakh unutilized for a new manufacturing facility and invested in fixed deposits.

*this image is generated using AI for illustrative purposes only.
Arunaya Organics reported a 12% decline in net profit to ₹371.85 lakh for the financial year ended March 31, 2026, despite a 25% increase in revenue from operations to ₹10,324.78 lakh. The board approved the audited financial results for the half-year and year ended March 31, 2026, in a meeting held on May 30, 2026. The statutory auditor, M/s. Abhishek Kumar & Associates, issued a qualified opinion regarding the company's compliance with foreign exchange regulations and working capital management. Notably, the audit qualification appeared for the first time, and the auditor confirmed that the financial figures remain unchanged even after adjusting for the qualification.
Financial Performance
Total income for FY26 rose to ₹10,487.65 lakh from ₹8,285.60 lakh in the previous year. Total expenses increased to ₹9,873.21 lakh from ₹7,730.86 lakh. The profit before tax for the year stood at ₹614.44 lakh, compared to ₹554.74 lakh in the previous year. Earnings per share (basic and diluted) decreased to ₹2.18 from ₹3.48 in the previous year. The decline in net profit, despite higher revenue and pre-tax profit, was primarily driven by a significantly higher tax expense of ₹242.59 lakh in FY26 compared to ₹132.65 lakh in the previous year, which included a tax expense of earlier years amounting to ₹70.82 lakh.
| Metric | FY26 (₹ in lakh) | FY25 (₹ in lakh) |
|---|---|---|
| Revenue from Operations | 10,324.78 | 8,265.96 |
| Total Income | 10,487.65 | 8,285.60 |
| Total Expenses | 9,873.21 | 7,730.86 |
| Profit Before Tax | 614.44 | 554.74 |
| Tax Expense | 242.59 | 132.65 |
| Net Profit | 371.85 | 422.09 |
| EPS (Basic & Diluted) | 2.18 | 3.48 |
Balance Sheet Highlights
As at March 31, 2026, the company's total assets stood at ₹9,005.53 lakh, up from ₹6,113.88 lakh in the previous year. Shareholders' funds increased significantly to ₹4,867.73 lakh from ₹1,692.17 lakh, reflecting the capital infusion from the IPO. Inventories rose to ₹4,367.66 lakh from ₹3,210.37 lakh, while trade receivables increased to ₹2,062.41 lakh from ₹1,440.81 lakh. Cash and cash equivalents grew substantially to ₹917.38 lakh from ₹6.61 lakh at the start of the year.
| Balance Sheet Item | FY26 (₹ in lakh) | FY25 (₹ in lakh) |
|---|---|---|
| Total Assets | 9,005.53 | 6,113.88 |
| Shareholders' Funds (Net Worth) | 4,867.73 | 1,692.17 |
| Inventories | 4,367.66 | 3,210.37 |
| Trade Receivables | 2,062.41 | 1,440.81 |
| Cash and Cash Equivalents | 917.38 | 6.61 |
| Short-Term Borrowings | 1,999.54 | 1,291.11 |
Auditor's Qualified Opinion
The auditor highlighted that certain payments for import transactions and receivables from export transactions remained outstanding for a period exceeding six months. This delay may have implications on the company's compliance with the Foreign Exchange Management Act, 1999 (FEMA) and could potentially impact its creditworthiness and business relationships with overseas partners. The management stated that the delays were due to pending payment approvals from the Reserve Bank of India and that the financial results for the year were not impacted by these matters. The audit qualification appeared for the first time, and the audited and adjusted figures remain identical across all key metrics.
Capital Allocation and IPO Proceeds
The company raised ₹3,050.80 lakh through its Initial Public Offer in May 2025, issuing 52,60,000 equity shares of ₹10 each at a premium of ₹48 each, and got listed on the Emerge SME Platform of National Stock Exchange of India Limited on May 7, 2025. As of March 31, 2026, the company utilized ₹2,150.80 lakh of the proceeds. A significant portion of the funds earmarked for setting up a new manufacturing facility at Dahej, Bharuch, Gujarat, amounting to ₹900.00 lakh, remained unutilized and were invested in fixed deposits. The company subsequently obtained an overdraft limit against these deposits, which was utilized for general business activities and advances. The Audit Committee confirmed there is no deviation in the use of IPO proceeds from the objects stated in the Prospectus.
| Object | Amount Allotted (₹ in lakh) | Amount Utilised (₹ in lakh) | Amount Unutilised (₹ in lakh) |
|---|---|---|---|
| Setting Up of New Manufacturing Facility | 1,178.95 | 278.95 | 900.00 |
| To Meet Working Capital Requirements | 900.00 | 900.00 | - |
| Issue Related Expenses | 298.98 | 298.98 | - |
| General Corporate Purpose | 672.87 | 672.87 | - |
| Total | 3,050.80 | 2,150.80 | 900.00 |
Board and Governance Changes
The board reconstituted the Stakeholder Relationship Committee by appointing Mr. Vinod Brijmohandas Agrawal as a member effective May 30, 2026. The committee now comprises Mr. Ashokbhai Divanchand Agrawal as Chairman, Mr. Umesh Krishnankutty Menon, Mrs. Amita Chhaganbhai Pragada, and Mr. Vinod Brijmohandas Agrawal as members. Additionally, the board appointed M/s. G R Shah & Associates as the Secretarial Auditors for the financial year 2025-26. Mr. Gaurang Shah, Proprietor of M/s. G R Shah & Associates, holds vast experience in legal, compliance, secretarial compliances, listing compliance, FEMA compliances, and management consultancy.
| Committee Member | Designation | Nature of Directorship |
|---|---|---|
| Mr. Ashokbhai Divanchand Agrawal | Chairman | Non-Executive Director |
| Mr. Umesh Krishnankutty Menon | Member | Non-Executive Independent Director |
| Mrs. Amita Chhaganbhai Pragada | Member | Non-Executive Independent Director |
| Mr. Vinod Brijmohandas Agrawal | Member | Managing Director |
Historical Stock Returns for Arunaya Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.70% | -20.31% | -7.44% | -2.96% | -48.65% | -42.88% |
What specific measures is management taking to resolve the pending RBI approvals and clear the qualified audit opinion regarding FEMA compliance?
How will the company utilize the ₹900 lakh unutilized IPO proceeds currently parked in fixed deposits, and what is the revised timeline for the Dahej facility?
Will the significant increase in tax expenses normalize in the coming year, or should investors anticipate a higher effective tax rate going forward?


























